ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BTG Btg Plc

840.00
0.00 (0.00%)
15 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Btg Plc LSE:BTG London Ordinary Share GB0001001592 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 840.00 839.00 840.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Btg Share Discussion Threads

Showing 4176 to 4197 of 6225 messages
Chat Pages: Latest  177  176  175  174  173  172  171  170  169  168  167  166  Older
DateSubjectAuthorDiscuss
01/11/2016
08:32
Is that a cyber attack or a disaster looming!
fhmktg
31/10/2016
17:42
Fhmktg

Hope we make it , it is a lonely board following BTG . Strange why so little people follow this.

bargainbob
31/10/2016
11:47
Lemtrada with us until December 2017 so some very useful cash flow until then.November 15th for update numbers. Currency will have helped again. Varithena will probably disappoint again, but submission of PneumRx to FDA should come in next two months.The outcome of TrumpvClinton is weighing on sentiment for the US healthcare sector and general pessimism for the world markets.BTG has a terrific story to tell with over 20% compound growth in revenue and excellent margins.I just hope I'm still here to see the share price double over the next few years!
fhmktg
28/10/2016
16:24
posted by Dave Gasser

Just been taking a look a sanofi third quarter sales of Lemtrada® they have increased by 69.1% to €112 million, including €64 million in the U.S. (up 66.7%) and €37 million in Europe (up 81.8%), mainly generated in the UK. Year-to-date sales of Lemtrada® were up 95.1% to €308 million. that should help the bottom line.
It's a pity BTG stoped issuing quarterly results as they are so handy .

hxxp://mediaroom.sanofi.com/sanofi-announces-strong-q3-2016-results/

BE HAPPY
Dave

bargainbob
28/10/2016
16:20
Crying out for a pay back here . No , share growth or divi.
bargainbob
28/10/2016
13:31
Painful it is as well!
fhmktg
28/10/2016
12:39
FTSE 100 up and BTG loosing ground again on no news and no volume
2 RECOMMENDATIONS UPGRADES LAST WEEK RAISING TARGET PRICES to 860-900p by Deutsche and Numis , but market wants BTG down - this is reality ....

a1ord53
20/10/2016
17:37
BTG plc (BTG) Upgraded to “Buy” at Numis Securities Ltd

Posted by Trent Williams on Oct 17th, 2016 // No Comments

BTG plc logoBTG plc (LON:BTG) was upgraded by equities researchers at Numis Securities Ltd to a “buy” rating in a research note issued on Monday. The firm currently has a GBX 900 ($11.14) price target on the stock. Numis Securities Ltd’s target price points to a potential upside of 29.87% from the stock’s previous close.

a1ord53
19/10/2016
08:40
biotec flying in USA yesterday .Surprised no pull through here today.
bargainbob
14/10/2016
09:05
Oh thanks I see it now .
bargainbob
14/10/2016
08:31
It's on the news section for today.A software certification for aiding Therasphere.
fhmktg
14/10/2016
08:28
Is it on the BTG website.
bargainbob
14/10/2016
07:34
Another brick in the competency wall today. Credibility with the academic community grows.Now that's how to grow a business!Well done the Therasphere team.
fhmktg
07/10/2016
18:58
Share of the week
[...]

bargainbob
07/10/2016
09:57
The henny-penny theory of investment does not seem to be working here. It never makes sense with a solid company like BTG to rush about the street shouting "The sky is falling" when the share price drops. Much better to take the opportunity to buy. CT's (and others') gloomy prognostications seem to have been completely wrong again.
muffmitz
07/10/2016
08:10
A balanced piece in the Telegraph today rather unfortunately headed "Inside KTG!"listing pros and cons
steeplejack
07/10/2016
07:22
Does the cash from the settlement for the claim against Biocompatibles come from BTG or from the previous owners and their insurers ?
fhmktg
07/10/2016
06:35
Oh dear - Tempus is having a bad day!
Having previously been a fan of BTG, 'Tempus' (The Times) now says "On 36 times earnings, I would wait for a further period of price weakness to buy" and concludes "Avoid - long term picture is good but multiple looks high".
This seams a bit contrarian given that I am sure Tempus has recommended to buy BTG at higher multiples/higher share price before, perhaps he has been influenced by CT!
To to fair, I think Tempus is having a bad day because he also recommends buying BAE (despite its insane pension deficit) and buying DFS (despite the fact that they just sell ... er ... Sofas!).
I think he should go and lie down in a darkened room for a bit.

spyder
06/10/2016
21:10
The broker reports will follow shortly , will the £7 hold Captain.
bargainbob
06/10/2016
19:59
I agree gregmorg.
Other good quotes from the article that CT kindly referred to us (thanks CT) include - "the good news is that this product works extraordinarily well. There is not a patient that we're aware of who hasn't responded well" & 'Day by day, BTG sees more physicians using Varithena'.
It has been very very slow, but perhaps there are some nascent signs of the success of Varithens.

spyder
06/10/2016
15:43
£3 by Xmas, then? LOL
harijan
06/10/2016
15:17
Good news ref lc bead. Still not convinced ref varithena.
cockneytrader
Chat Pages: Latest  177  176  175  174  173  172  171  170  169  168  167  166  Older

Your Recent History

Delayed Upgrade Clock